AP
Appili Therapeutics Inc
APLIF · OTC
$0.01 +0.00% (+$0.00)
1M -8.59%
Market Cap $1.81M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
11.1% upside
Current Price
$0.009
Undervalued Fair Value Overvalued
According to Bulios Fair Price, APLIF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
37 /100
Fair P/S 4.76x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 9.85%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 99.32%
FCF margin 347.84%
Net margin 1,236.57%
Quality
62 /100
Average ROIC 105.02%
Asset turnover 0.29x
ROA 361.55%
Debt
0 /100
High Current ratio 0.07x
Int. coverage -5.88x
Debt/Equity N/A
Stability
20 /100
Unstable Beta -0.21x
Profitable years 0
Rev. volatility 134.84%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about APLIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Don Cilla
Employees
7
Headquarters
Halifax
Upcoming events
12 NOV
Earnings
Upcoming earnings report